Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Metabolism. 2018 Sep 15;89:1–7. doi: 10.1016/j.metabol.2018.09.003

Table:

Summary of 25OHD Levels Obtained in Elderly RCT using LC-MS/MS and Diasorin Liaison 25OHD Assays

Test N Mean ± SD Median Minimum Maximum p-value
Baseline AUB (Diasorin Liaison) (ng/ml) 219 18.5 ± 7.8 16.6 4 45.9 <0.0001
Mayo (LC-MS/MS) (ng/ml) 219 20.5 ± 7.6 19 6 45
Difference (ng/ml)* 219 2 ± 6.2 1.7 −30.9 19.2
Difference (%) 219 6.9 ± 29.3 10 −206 61.9
6 months AUB (Diasorin Liaison) (ng/ml) 171 28.1 ± 9.9 26.8 8.6 61 <0.0001
Mayo (LC-MS/MS) (ng/ml) 171 30.4 ± 10 29 11 68
Difference (ng/ml)* 171 2.3 ± 7.4 2.7 −17.5 28.4
Difference (%) 171 5.8 ± 23.2 10 −76.1 67
12 months AUB (Diasorin Liaison) (ng/ml) 126 28.5 ± 9.5 26.5 9.7 54.2 0.001
Mayo (LC-MS/MS) (ng/ml) 126 30.9 ± 10.2 28 14 65
Difference (ng/ml)* 126 2.4 ± 7.6 2.7 −26.8 28.3
Difference (%) 126 5.1 ± 26.4 9.5 −167.5 60.9
All AUB (Diasorin Liaison) (ng/ml) 516 24.1 ± 10.2 23.3 4 61 <0.0001
Mayo (LC-MS/MS) (ng/ml) 516 26.3 ± 10.4 25 6 68
Difference (ng/ml)* 516 2.2 ± 6.9 2.2 −30.9 28.4
Difference (%) 516 6.1 ± 26.7 9.8 −206 67
*

Difference= 25OHD (LC-MS/MS) - (Diasorin Liaison)

%Difference= (LC-MS/MS -Diasorin Liaison)/ LC-MS/MS *100